Novartis AG
NVS | NYSE
$142.53
+$1.25 (+0.88%)
At close: Sep 23, 2026, 3:43 PM ET
$143.32
+$0.79 (+0.55%)
Pre-market:
Sep 24, 2026, 8:12 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 28, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 12.76B | 13.52B | 13.97B | 14.38B | 13.64B | 12.86B | 11.94B | 11.8B | 10.13B | 9.15B | 8.76B | 7.54B | 7.36B | 6.79B | 6.71B | 21.55B | 22.98B | 24.18B | 24.02B | 9.81B | 8.99B | 7.96B |
Depreciation & Amortization | 5.34B | 5.4B | 5.32B | 5.4B | 6B | 5.91B | 6.07B | 6.06B | 7.2B | 7.75B | 8.43B | 8.76B | 7.57B | 7.66B | 7.07B | 6.64B | 6.18B | 5.82B | 6.11B | 6.21B | 6.49B | 6.75B |
Stock-Based Compensation | 571M | 838M | 797M | 1.07B | 1.06B | 1.05B | 1.04B | 772M | 517M | 482M | 412M | 609M | 817M | 799M | 812M | 810M | 775M | 756M | 736M | 700M | 729M | 743M |
Other Working Capital | -1.12B | -449.46M | -922.46M | 989M | 160M | 263M | 339M | -212M | 610M | 325M | 736M | 1.78B | 1.28B | 1.2B | 377M | 1.6B | 1.35B | 939M | 412M | 458M | -158M | 362M |
Other Non-Cash Items | 792.86M | -745.32M | -241.32M | -1.82B | -1.38B | -2.17B | -2.21B | -355.56M | -918.56M | -1.38B | -1.4B | -2.63B | -1.35B | -509M | -652M | -16.25B | -17.15B | -18.05B | -18.16B | -3.75B | -4.57B | -4.31B |
Deferred Income Tax | 949M | 1.46B | 1.57B | 2.04B | 1.97B | 2.06B | 1.7B | -639M | -839M | -1.03B | -1.03B | 1.12B | 1.38B | 1.33B | 1.33B | 1.7B | 1.91B | 2.18B | 2.12B | 1.93B | 1.94B | 1.75B |
Change in Working Capital | -2.03B | -1.3B | -2.28B | 15M | -497M | -701M | -922M | -1.66B | -1.02B | -1.21B | -720M | 602M | -417M | -526M | -1.03B | -442M | -480M | -296M | 241M | 287M | -158M | 362M |
Operating Cash Flow | 18.39B | 19.16B | 19.13B | 21.07B | 20.79B | 19B | 17.62B | 15.97B | 15.07B | 13.77B | 14.46B | 16.02B | 15.37B | 15.54B | 14.24B | 14.01B | 14.21B | 14.59B | 15.07B | 15.19B | 13.42B | 13.25B |
Capital Expenditures | -2.57B | -2.81B | -3.49B | -4.01B | -3.98B | -4.15B | -3.81B | -3.09B | -2.41B | -2.58B | -1.89B | -2.13B | -2.49B | -2.17B | -2.56B | -2.89B | -2.96B | -2.97B | -2.97B | -3.02B | -3.11B | -2.96B |
Cash Acquisitions | -15.65B | -15.05B | -3B | -2.1B | -1.99B | -3.64B | -3.91B | -3.49B | -6.83B | -3.59B | -3.37B | -3.53B | -133M | -108M | -905M | 19.44B | 19.42B | 19.47B | 20.1B | -177M | -272M | -272M |
Purchase of Investments | -281.13M | -293.13M | -294.13M | -2.52B | -3.43B | -3.65B | -3.65B | -1.92B | -947M | -695M | -752M | -10.75B | -17.42B | -30.67B | -34.81B | -39.87B | -33.97B | -20.78B | -16.61B | -1.14B | -1.87B | -1.89B |
Sales Maturities Of Investments | 1.19B | 1.46B | 2.17B | 2.69B | 3.98B | 5.01B | 3.7B | 3.3B | 2.11B | 1.09B | 11.6B | 21.08B | 33.25B | 35.35B | 39.49B | 30.52B | 18.08B | 16.18B | 2.76B | 2.38B | 2.51B | 2.45B |
Other Investing Acitivies | -577.14M | -1.02B | -1.81B | -2.38B | -2.42B | -2.61B | -2.29B | -1.89B | -640M | -991M | 99M | 45M | -1.08B | -506M | -1.17B | -1.39B | -1.13B | -685M | -50M | 63M | 217M | -92M |
Investing Cash Flow | -17.8B | -16.95B | -4.88B | -5.81B | -5.32B | -6.28B | -7.51B | -5.59B | -8.08B | -5.92B | 5.6B | 5.24B | 13.3B | 2.72B | 1.47B | 7.5B | 1.07B | 12.79B | 4.21B | -926M | -1.74B | -2.26B |
Debt Repayment | 16.59B | 14.62B | 2.52B | -959M | 2.06B | 2.77B | 4.45B | 5.23B | 2.28B | 610M | 390M | -1.56B | -3.13B | -2.02B | -2.55B | -4.32B | -3.57B | -6.27B | -5.92B | -3.91B | 169M | 295M |
Common Stock Repurchased | -6.85B | -8.37B | -9.21B | -10.49B | -11.05B | -9.95B | -8.33B | -6.82B | -5.59B | -6.93B | -8.72B | -10.15B | -11.24B | -11B | -10.65B | -8.12B | -5.69B | -3.68B | -3.06B | -4.68B | -5.32B | -4.62B |
Dividend Paid | -9.02B | -8.64B | -7.78B | -7.79B | -7.82B | -7.75B | -7.62B | -7.62B | -7.62B | -5.21B | -7.26B | -7.26B | -7.26B | -7.26B | -7.51B | -7.51B | -7.51B | -7.51B | -7.37B | -7.37B | -7.37B | -7.37B |
Other Financial Acitivies | -259.61M | -320.31M | -374.31M | -304.8M | -337M | -226M | -261M | -158M | 1.12B | 1.3B | 1.31B | 1.29B | 49M | 36M | 146M | 133M | 150M | 204M | 83M | 3M | 1M | -65M |
Financial Cash Flow | 472.2M | -2.71B | -14.84B | -19.55B | -17.14B | -15.13B | -11.74B | -9.35B | -9.8B | -10.24B | -14.28B | -17.67B | -21.57B | -20.24B | -20.56B | -19.82B | -16.62B | -17.25B | -16.26B | -15.95B | -12.52B | -11.76B |
Net Cash Flow | 960.07M | -188.95M | -23.95M | -4.05B | -1.25B | -2.4B | -1.93B | 1.2B | -2.98B | -2.53B | 5.88B | 3.68B | 7.26B | -1.85B | -4.89B | 1.52B | -1.49B | 10.05B | 2.75B | -1.78B | -800M | -727M |
Free Cash Flow | 15.82B | 16.36B | 15.64B | 17.06B | 16.81B | 14.85B | 13.81B | 12.88B | 12.66B | 11.19B | 12.57B | 13.89B | 12.88B | 13.37B | 11.68B | 11.12B | 11.26B | 11.62B | 12.1B | 12.18B | 10.32B | 10.29B |
Adj. Free Cash Flow | 15.25B | 15.52B | 14.84B | 15.99B | 15.75B | 13.8B | 12.76B | 12.11B | 12.14B | 10.71B | 12.16B | 13.28B | 12.06B | 12.57B | 10.86B | 10.31B | 10.48B | 10.86B | 11.36B | 11.48B | 9.59B | 9.55B |
Maintenance CapEx | -2.27B | -2B | -2.3B | -2.33B | -2.31B | -2.67B | -2.43B | -2.19B | -1.69B | -2.17B | -1.77B | -2.02B | -2.49B | -2.17B | -2.52B | -2.7B | -2.5B | -1.99B | -2.03B | -2.13B | -2.46B | -2.84B |
Growth CapEx | -304.66M | -809.17M | -1.19B | -1.68B | -1.67B | -1.48B | -1.39B | -897.97M | -718.29M | -409.76M | -116M | -116M | n/a | n/a | -37.22M | -192.25M | -453.47M | -980.31M | -943.09M | -886.85M | -643.25M | -116.41M |
Owner Earnings | 16.12B | 17.17B | 16.83B | 18.74B | 18.48B | 16.32B | 15.19B | 13.78B | 13.38B | 11.6B | 12.68B | 14.01B | 12.88B | 13.37B | 11.71B | 11.31B | 11.71B | 12.6B | 13.04B | 13.06B | 10.96B | 10.41B |
Add to Watchlist
Select watchlists to add or remove NVS